These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28832488)

  • 1. Committee Opinion No. 717: Sulfonamides, Nitrofurantoin, and Risk of Birth Defects.
    Obstet Gynecol; 2017 Sep; 130(3):e150-e152. PubMed ID: 28832488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Committee Opinion No. 717 Summary: Sulfonamides, Nitrofurantoin, and Risk of Birth Defects.
    Obstet Gynecol; 2017 Sep; 130(3):666-667. PubMed ID: 28832479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects.
    Obstet Gynecol; 2011 Jun; 117(6):1484-1485. PubMed ID: 21606771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.
    Crider KS; Cleves MA; Reefhuis J; Berry RJ; Hobbs CA; Hu DJ
    Arch Pediatr Adolesc Med; 2009 Nov; 163(11):978-85. PubMed ID: 19884587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrofurantoin and congenital abnormalities.
    Czeizel AE; Rockenbauer M; Sørensen HT; Olsen J
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):119-26. PubMed ID: 11267733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.
    Ailes EC; Gilboa SM; Gill SK; Broussard CS; Crider KS; Berry RJ; Carter TC; Hobbs CA; Interrante JD; Reefhuis J;
    Birth Defects Res A Clin Mol Teratol; 2016 Nov; 106(11):940-949. PubMed ID: 27891788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis.
    Goldberg O; Moretti M; Levy A; Koren G
    J Obstet Gynaecol Can; 2015 Feb; 37(2):150-156. PubMed ID: 25767948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions in children during long-term antimicrobial therapy.
    Uhari M; Nuutinen M; Turtinen J
    Pediatr Infect Dis J; 1996 May; 15(5):404-8. PubMed ID: 8724061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of nitrofurantoin in pregnancy].
    Urbina O; Ferrández O; Salas E; Grau S
    Enferm Infecc Microbiol Clin; 2010; 28(6):403. PubMed ID: 20430481
    [No Abstract]   [Full Text] [Related]  

  • 10. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
    Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
    J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of drugs commonly used in the treatment of urinary tract infection. A report from the Australian Drug Evaluation Committee.
    Med J Aust; 1972 Feb; 1(9):435-8. PubMed ID: 5024405
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women.
    Malik RD; Wu YR; Christie AL; Alhalabi F; Zimmern PE
    Urology; 2018 Mar; 113():26-33. PubMed ID: 29196069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study.
    Czeizel AE; Rockenbauer M; Sørensen HT; Olsen J
    Reprod Toxicol; 2001; 15(6):637-46. PubMed ID: 11738517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin and pregnancy.
    Cimolai N; Cimolai T
    CMAJ; 2007 Jun; 176(13):1860-1. PubMed ID: 17576987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy].
    Bruel H; Guillemant V; Saladin-Thiron C; Chabrolle JP; Lahary A; Poinsot J
    Arch Pediatr; 2000 Jul; 7(7):745-7. PubMed ID: 10941490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal outcomes after gestational exposure to nitrofurantoin.
    Nordeng H; Lupattelli A; Romøren M; Koren G
    Obstet Gynecol; 2013 Feb; 121(2 Pt 1):306-313. PubMed ID: 23344280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections - United States, 2014.
    Ailes EC; Summers AD; Tran EL; Gilboa SM; Arnold KE; Meaney-Delman D; Reefhuis J
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(1):18-22. PubMed ID: 29324733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
    Stock I
    Med Monatsschr Pharm; 2014 Jul; 37(7):242-8. PubMed ID: 25065160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.
    Hansen C; Andrade SE; Freiman H; Dublin S; Haffenreffer K; Cooper WO; Cheetham TC; Toh S; Li DK; Raebel MA; Kuntz JL; Perrin N; Rosales AG; Carter S; Pawloski PA; Maloney EM; Graham DJ; Sahin L; Scott PE; Yap J; Davis R
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):170-8. PubMed ID: 26599424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy.
    Czeizel AE; Rockenbauer M; Sørensen HT; Olsen J
    Clin Nephrol; 2000 Apr; 53(4):257-63. PubMed ID: 10809412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.